What is the new drug for MRSA? Zevtera and the latest treatment innovations
•
5 min read
In April 2024, the US Food and Drug Administration (FDA) approved the novel cephalosporin antibiotic Zevtera (ceftobiprole medocaril), providing a new answer to the urgent question, "What is the new drug for MRSA?". This milestone introduces a crucial new weapon against a persistent and deadly superbug, offering physicians an additional tool for serious and complex infections.
